Buscar
Mostrando ítems 1-10 de 37
Neuroprotection targeting protein misfolding on chronic cerebral hypoperfusion in the context of metabolic syndrome
(Frontiers Media S.A., 2018-05)
Metabolic syndrome (MetS) is a cluster of risk factors that lead to microvascular dysfunction and chronic cerebral hypoperfusion (CCH). Long-standing reduction in oxygen and energy supply leads to brain hypoxia and protein ...
Chronic cerebral hypoperfusion alters amyloid-β peptide pools leading to cerebral amyloid angiopathy, microinfarcts and haemorrhages in Tg-SwDI mice
(Portland Press Ltd., 2017)
Cerebral hypoperfusion is an early feature of Alzheimer's disease (AD) that influences the progression from mild cognitive impairment to dementia. Understanding the mechanism is of critical importance in the search for new ...
Neuroprotection targeting protein misfolding on chronic cerebral hypoperfusion in the context of metabolic syndrome
(Frontiers Media S.A., 2018)
SHORT-TERM PROGNOSIS FOR SPEECH AND LANGUAGE IN FIRST STROKE PATIENTS
(Assoc Arquivos Neuro- PsiquiatriaSao Paulo SpBrasil, 2009)
Estudo do sistema purinérgico e colinérgico no encéfalo de animais submetidos à hipoperfusão encefálica crônica e ao ambiente enriquecido
(Universidade Federal de Santa MariaBrasilBioquímicaUFSMPrograma de Pós-Graduação em Ciências Biológicas: Bioquímica ToxicológicaCentro de Ciências Naturais e Exatas, 2016-08-19)
Chronic cerebral hypoperfusion (CCH) has frequently been associated with neurodegenerative diseases. A persistent reduction of cerebral blood flow (CBF) changes the neuronal homeostasis causing diffuse ischemic damage and ...
Efeitos da Atorvastatina (Citalor®) sobre as sequelas neurohistológicas e comportamentais induzidas por hipoperfusão cerebral crônica em ratos de meia-idadeEffects of Atorvastatin (Citalor®) on the behavioral and neurohistological sequelae after chronic cerebral hypoperfusion in middle-aged rats
(Universidade Estadual de MaringáBrasilDepartamento de Farmacologia e TerapêuticaPrograma de Pós-Graduação em Ciências FarmacêuticasUEMMaringá, PRCentro de Ciências da Saúde, 2018)
Neuroprotection targeting protein misfolding on chronic cerebral hypoperfusion in the context of metabolic syndrome
(Frontiers Media, 2018)
Abstract: Metabolic syndrome (MetS) is a cluster of risk factors that lead to microvasculardysfunction and chronic cerebral hypoperfusion (CCH). Long-standing reduction inoxygen and energy supply leads to brain hypoxia and ...